Tumour eosinophilia combined with an immunohistochemistry panel is useful in the differentiation of type B3 thymoma from thymic carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/21044186

Download in:

View as

General Info

PMID
21044186